1. Seronie-Vivien S, Delanaye P, Pieroni L, Mariat C, Froissart M, Cristol JP (2008): Cystatin C: Current position and future prospects. Clinical Chemistry and Laboratory Medicine 46, 1664–1686.
2. Wyss M, Kaddurah-Daouk R (2000): Creatine and creatinine metabolism. Physiological Reviews 80, 1107–1203.
3. Harris RC, Lowe JA, Warnes K, Orme CE (1997): The concentration of creatine in meat, offal and commercial dog food. Research on Veterinary Science 62, 58–62.
4. Wolford ST, Schroer RA, Gohs FX, Gallo PP, Falk HB, Dente AR (1988): Effect of age on serum chemistry profile, electrophoresis and thyroid hormones in beagle dogs two weeks to one year of age. Veterinary Clinical Pathology 17, 35–42.
5. Fukuda S, Kawashima N, Iida H, Aoki J, Tokita K (1989): Age dependency of hematological values andconcentrations of serum biochemical constituents in normal beagles from 1 to 14 years of age.Japanese Journal of Veterinary Science 51, 636–641.
6. Craig AJ, Sequela J, Queau Y, Murgier P, Concordet D, Fleeman LM, Mimouni P, Braun JP, Germain C, Lefebvre HP (2006): Redefining the reference interval for plasma creatinine in dogs: effect of a ge, gender, body weight and breed. Journal of Veterinary Internal Medicine 20, 740.
7. Braun JP, Lefebvre HP, Watson AD (2003): Creatinine in the dog: a review. Veterinary Clinical Pathology 32, 162–179.
8. Braun JP, Cabe E, Geffre A, Lefebvre HP, Trumel C (2008): Comparison of plasma creatinine values measured by different veterinary practices. Veterinary Record 162, 215–216.
9. Tenstad O, Roald AB, Grubb A, Aukland K (1996): Renal handling of radiolabelled human cystatin C in the rat. Scandinavian Journal of Clinical and Laboratory Investigation 56, 409–414.
10. Kaseda R, Iino N, Hosojima M, Takeda T, Hosaka K, Kobayashi A, Yamamoto K, Suzuki A, Kasai A, Suzuki Y, Gejyo F, Saito A (2007): Megalin-mediated endocytosis of cystatin C in proximal tubule cells. Biochemical and Biophysical Research Communications 357, 1130–1134
11. Miyagawa Y, Takemura N, Hirose H (2009): Evaluation of the measurement of serum cystatin C by an enzyme-linked immunosorbent assay for humans as a marker of the glomerular filtration rate in dogs. Journal of Veterinary Medical Science 71, 1169–1176.
12. Chanoit G, Concordet D, Lefebvre HP, Orcel K, Braun JP (2002): Exercise does not induce major changes in plasma muscle enzymes, creatinine, glucose and total proteins concentrations in untrained beagle dogs. Journal of Veterinary Medicine A, Physiology, Pathology, Clinical Medicine 49, 222–224.
13. Wehner A, Hartmann K, Hirschberger J (2008): Utility of serum cystatin C as a clinical measure of renal function in dogs. Journal of American Animal Hospital Association 44, 131–138.
14. Pagitz M, Frommlet F, Schwendenwein I (2007): Evaluation of biological variance of cystatin C in comparison with other endogenous markers of glomerular filtration rate in healthy dogs. Journal of Veterinary Internal Medicine 21, 936–942.
15. Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C (2003): Impact of thyroid dysfunction on serum cystatin C. Kidney International 63, 1944–1947.
16. Kakimoto Y, Akazawa S (1970): Isolation and identification of NG, NG- nad NG,N'G-dimethylarginine, N蔚 -mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-未-hydroxylysine from human urine. Journal of Biological Chemistry 245, 57515758.
17. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction by Claudia Korandji et al.
18. Symmetrical Dimethylarginine Predicts Mortality in the General Population Observations From the Dallas Heart StudyM. Odette Gore et al.
19. Symmetrical Dimethylarginine Predicts Mortality in the General Population Observations From the Dallas Heart StudyM. Odette Gore et al.
20. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction by Claudia Korandji et al.
21. Symmetrical and Asymmetrical Dimethylarginine as Predictors for Mortality in Patients Referred for Coronary Angiography: The Ludwigshafen Risk and Cardiovascular Health Study by Andreas Meinitzer et al.
22. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure by Masato OHNISHI et al.
23. The Human Liver Clears Both Asymmetric and Symmetric DimethylarginineMichiel P.C. Siroen et al.
24. Acetylation of asymmetric and symmetric dimethylarginine: an undercharacterized pathway of metabolism of endogenous methylargininesRoman N. Rodionov et al.
25. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent riskfactor of ICU mortality R. J. NIJVELDT et al.
26. Changes in Biliary Levels of Arginine and its Methylated Derivatives after Hepatic Ischaemia/ReperfusionAndrea Ferrigno et al.
27. The conjoint detrimental effect of chronic periodontal disease and systemic inﬂammation on asymmetric dimethyl-arginine in untreated hypertensive subjects by Costas Tsiouﬁs et al.
28. INCREASE OF AN ENDOGENOUS INHIBITOR OF NITRIC OXIDE SYNTHESIS IN SERUM OF HIGH CHOLESTEROL FED RABBITS by Xian-jie Yu et al.
29. Effects of Aspirin on Endothelial Function and HypertensionMikhail S. Dzeshka et al.
30. Monitoring of L-Arginine and Endogenous Dimethylarginines in Survivor Septic Patients – A Pilot Study BALÁZS NÉMETH et al.